Ophthalmic Injectable Market

Future Market Insights

Key Insight

The ophthalmic injectable market is projected to grow from USD 20.7 billion in 2025 to USD 32.6 billion by 2035, at a CAGR of 4.7%. Anti-VEGF will dominate with a 54.7% market share, while macular degeneration will lead the indication segment with a 47.9% share.

September 26, 2025

Anurag Sharma

250 Pages

Cite this Report

Ophthalmic Injectable Market

https://www.futuremarketinsights.com/reports/ophthalmic-injectable-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Bristol-Myers Squibb
Novartis

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Ophthalmic Injectable Market

Key Players

Similar Industry Reports